Parra-Damas A. and Saura C.A. Tissue clearing and expansion methods for imaging brain pathology in neurodegeneration: from circuits to synapses and beyond.
Front Neuroscience. 2020,14:914. doi:10.3389/fnins.2020.00914

Javier-Torrent M. and Saura C.A. Conventional and non-conventional roles of non-muscle myosin II-actin in neuronal development and degeneration.
Cells 9 (9), E1926.2020. doi: 10.3390/cells9091926

Parra-Damas A. and Saura C.A. Synapse-to-nucleus signaling in neuropsychiatric and neurodegenerative disorders.
Biol Psychiatry.2019,86:87-96. https://doi.org/10.1016/j.biopsych.2019.01.006

Saura C.A. and Cardinaux J-R.  Emerging roles of CREB-regulated transcription coactivators in brain physiology and pathology.
Trends in Neurosciences. 2017, 40(12):720-733. doi: 10.1016/j.tins.2017.10.002.

Saura C.A., Parra-Damas A., Enriquez-Barreto L. Gene expression parallels synaptic excitability and plasticity changes in Alzheimer’s disease.
Front Cell Neurosci
. 2015. 9:318. doi: 10.3389/fncel.2015.00318.

Saura C.A. CREB regulated transcription coactivator 1-dependent transcription in Alzheimer’s disease mice.
Neurodegener Dis. 2012. 10(1-4):250-2. doi: 10.1159/000333341.

Saura C.A and Valero J. The role of CREB signaling in Alzheimer’s disease and other cognitive disorders.
Rev Neurosci. 2011. 22(2):153-169.  doi: 10.1515/RNS.2011.018

Lleó A. and Saura C.A. γ-Secretase substrates and their implications for drug development in Alzheimer’s disease.
Curr Top Med Chem.
2011. 11:1-15.

Saura C.A. Presenilin/γ-secretase and inflammation.
Front. Aging Neurosci. 2010. 2:16 doi: 10.3389/fnagi.2010.00016.